Dna X (SONM) Equity Average (2019 - 2025)
Historic Equity Average for Dna X (SONM) over the last 7 years, with Q3 2025 value amounting to -$1.0 million.
- Dna X's Equity Average fell 10619.99% to -$1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.0 million, marking a year-over-year decrease of 10619.99%. This contributed to the annual value of $8.3 million for FY2024, which is 6070.07% down from last year.
- Dna X's Equity Average amounted to -$1.0 million in Q3 2025, which was down 10619.99% from -$1.2 million recorded in Q2 2025.
- In the past 5 years, Dna X's Equity Average registered a high of $23.9 million during Q1 2021, and its lowest value of -$3.4 million during Q1 2025.
- Over the past 5 years, Dna X's median Equity Average value was $16.2 million (recorded in 2021), while the average stood at $14.1 million.
- Per our database at Business Quant, Dna X's Equity Average soared by 13479.18% in 2023 and then tumbled by 11606.13% in 2025.
- Over the past 5 years, Dna X's Equity Average (Quarter) stood at $15.6 million in 2021, then surged by 30.19% to $20.4 million in 2022, then grew by 11.7% to $22.7 million in 2023, then plummeted by 78.78% to $4.8 million in 2024, then tumbled by 121.09% to -$1.0 million in 2025.
- Its Equity Average was -$1.0 million in Q3 2025, compared to -$1.2 million in Q2 2025 and -$3.4 million in Q1 2025.